Has Competition Reassurance Helped Counter Combination Woes In The UK?

The rate of non-submissions for combination therapies in England has been on a downward trend in the last two years.

CMA logo
Competition concerns over combination products may be easing (Shutterstock)

More from Health Technology Assessment

More from Pathways & Standards